Search
USANA Health Sciences Inc
USNAAdd to Watchlist
22.110USD
-0.030-0.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
408.22MMarket Cap
44.63P/E TTM
More Details of USANA Health Sciences Inc Company
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
USANA Health Sciences Inc Info
Ticker SymbolUSNA
Company nameUSANA Health Sciences Inc
IPO dateOct 28, 1993
CEOBrown (Jim H)
Number of employees1700
Security typeOrdinary Share
Fiscal year-endOct 28
Address3838 West Parkway Blvd.
CitySALT LAKE CITY
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code84120-6336
Phone18019547100
Websitehttps://www.usana.com/
Ticker SymbolUSNA
IPO dateOct 28, 1993
CEOBrown (Jim H)
Company Executives of USANA Health Sciences Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin G. Guest
Mr. Kevin G. Guest
Executive Chairman of the Board
Executive Chairman of the Board
47.07K
-0.00%
Mr. Jim H. Brown
Mr. Jim H. Brown
President, Chief Executive Officer
President, Chief Executive Officer
17.45K
-38.10%
Dr. Timothy E. Wood, Ph.D.
Dr. Timothy E. Wood, Ph.D.
Independent Director
Independent Director
11.84K
+10.34%
Mr. Walter Noot
Mr. Walter Noot
Chief Operating Officer
Chief Operating Officer
9.26K
--
Ms. Xia Ding
Ms. Xia Ding
Independent Director
Independent Director
8.28K
+12.42%
Mr. John Turman Fleming
Mr. John Turman Fleming
Independent Director
Independent Director
5.86K
+27.84%
Mr. Paul A. Jones
Mr. Paul A. Jones
Chief People Officer
Chief People Officer
4.74K
-143.73%
Mr. Gilbert A. (Gil) Fuller, CPA
Mr. Gilbert A. (Gil) Fuller, CPA
Lead Independent Director
Lead Independent Director
574.00
-17.42%
Mr. G. Douglas Hekking
Mr. G. Douglas Hekking
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Frederic J. Winssinger
Mr. Frederic J. Winssinger
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin G. Guest
Mr. Kevin G. Guest
Executive Chairman of the Board
Executive Chairman of the Board
47.07K
-0.00%
Mr. Jim H. Brown
Mr. Jim H. Brown
President, Chief Executive Officer
President, Chief Executive Officer
17.45K
-38.10%
Dr. Timothy E. Wood, Ph.D.
Dr. Timothy E. Wood, Ph.D.
Independent Director
Independent Director
11.84K
+10.34%
Mr. Walter Noot
Mr. Walter Noot
Chief Operating Officer
Chief Operating Officer
9.26K
--
Ms. Xia Ding
Ms. Xia Ding
Independent Director
Independent Director
8.28K
+12.42%
Mr. John Turman Fleming
Mr. John Turman Fleming
Independent Director
Independent Director
5.86K
+27.84%
FAQs
Who are the top five shareholders of USANA Health Sciences Inc?
The top five shareholders of USANA Health Sciences Inc are: Mr. Kevin G. Guest
How many institutions hold shares of USANA Health Sciences Inc (USNA)?
As of 2026Q1, 371 institutions hold shares of USANA Health Sciences Inc, with a combined market value of approximately 11.35M, accounting for 61.48% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -673041.00.
What is the biggest source of revenue for USANA Health Sciences Inc?
In 2026Q1, the USANA® Nutritionals business generated the highest revenue for USANA Health Sciences Inc, amounting to 684.69M and accounting for 74.00% of total revenue.